Shao-chih Y. Chiu
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving In Vivo Generation of TCE-secreting CAR-Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 04, 2025
Engineered extracellular vesicles-mediated curcumin delivery in brain microenvironment modulating lysosomes, mitochondria, and microglia reprogram for parkinson's disease therapy.
Journal: Journal of nanobiotechnology
Published: September 30, 2025
Pemetrexed potentiates γδ T cell-based immunotherapy in NSCLC through ATM-STING-NF-κB-mediated induction of NKG2D ligands.
Journal: International immunopharmacology
Published: September 05, 2025
Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery.
Journal: Nature communications
Published: October 24, 2024
NF-кB promotes aggresome formation via upregulating HDAC6 and in turn maintaining Vimentin cage.
Journal: American journal of physiology. Cell physiology
Published: October 07, 2024
A New PD-L1 Nanobody Enhances Cell Death in Lung Cancer In Vitro and In Vivo.
Journal: Anticancer research
Published: April 15, 2024
High-yield extracellular vesicle production from HEK293T cells encapsulated in 3D auxetic scaffolds with cyclic mechanical stimulation for effective drug carrier systems.
Journal: Biofabrication
Published: March 23, 2024
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 11, 2023
The crescent-like Golgi ribbon is shaped by the Ajuba/PRMT5/Aurora-A complex-modified HURP.
Journal: Cell communication and signaling : CCS
Published: March 14, 2023
Last Updated: 09/26/2026